Nutex Health Inc.

NUTX Healthcare Medical Care Facilities

Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024.

Revenue
−13.6%
EPS
+424.8%
Free cash flow
+19.4%
Total debt
−1.69%

Quarter to June 2026, against a year earlier

181.64 12.00 −6.20%
Market cap
$1.3B
P/E
7.4×
Fwd P/E
7.3×
Dividend yield
—
F-score
7/9
Altman Z
3.27
Beneish M
−2.54
Dividend safety
41/100

Nutex Health Inc. (NUTX) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Nutex Health Inc. (NUTX) trades at a P/E ratio of 7.4×. Over the past ten years it has ranged from 0.0× (December 2024) to 144× (October 2021); the current reading is higher than 63% of that period. That is below the Medical Care Facilities industry median of 17.4× and below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 15.3× 381.19%
FY2024 3.2× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 14.5× 146.90%
FY2020 5.9× —
FY2019 0.0× —
FY2018 0.4× 0.00%
FY2017 0.4× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 6.5× (6.12%)
Mar 2026 6.9× (54.75%)
Dec 2025 15.3× 210.17%
Sep 2025 4.9× (56.70%)
39 more quarters

Against its own ten years

Low 0.0× High 144×
Ten-year median 4.5×
Current reading's percentile 33

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on NUTX